Diabetes Care Devices
US FDA approves Dexcom G7 CGM for all types of diabetes
The US Food and Drug Administration (FDA) has approved Dexcom's next-generation Dexcom G7 Continuous Glucose Monitoring (CGM) System for use…
Medtronic introduces new infusion set for insulin pumps in US
Medtronic has launched a new infusion set with a wear time of up to seven days for insulin pumps in…
Eli Lilly to launch diabetes management platform in US
Eli Lilly and Company has announced plans to start the rollout of its Tempo Personalized Diabetes Management Platform in the…
Diabetes devices: Easing the burden of care for women
Diabetes is a global health problem, with over 199 million women living with the condition, a figure that is expected…
Development of automated insulin delivery systems simplifies diabetes management
14 November is World Diabetes Day, which aims to raise awareness of diabetes and help improve the lives of the…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
NuraLogix researchers develop AI models for pre-diabetes risk prediction
NuraLogix researchers have developed new artificial intelligence (AI) models that can predict the risk of a person's HbA1C levels and…
MolecuLight’s device boosts healing by 204% in diabetic foot ulcer trial
MolecuLight has reported that the use of its MolecuLight i:X device to view the presence of increased bacterial burden in wounds raised…
Senseonics’ glucose monitoring system receives CE mark
Senseonics has obtained CE mark approval for its next-generation Eversense E3 continuous glucose monitoring (CGM) System, which can be used…
LumiraDx’s HbA1c test receives CE mark for diabetes screening
LumiraDx has reported that its HbA1c test received CE mark for the screening and monitoring of people with diabetes in…
Pancryos enters licence agreement for macroencapsulation device
Pancryos has entered a worldwide exclusive licence agreement with Brigham and Women's Hospital for the convection-enhanced macroencapsulation device (ceMED). A…
MannKind to acquire Zealand Pharma’s insulin delivery technology
MannKind Corporation has signed an asset purchase agreement for the V-Go insulin delivery device from Zealand Pharma. The transaction will…
Abbott, CamDiab and Ypsomed to develop automated insulin delivery system
Abbott, CamDiab and Ypsomed have entered a partnership to develop and market an integrated automated insulin delivery (AID) system to help patients…
US FDA approves Senseonics’ Eversense E3 CGM system
The US Food and Drug Administration (FDA) has approved the use of Senseonics’ Eversense E3 continuous glucose monitoring (CGM) system…
iQ Group files FDA pre-submission for saliva-based glucose test
The iQ Group Global has announced the filing of a pre-submission package to the US Food and Drug Administration (FDA)…
Cambridge University trials artificial pancreas in type 2 diabetes patients
A team of researchers at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust has developed an artificial…